Good for London, good for the UK.But all this progress seems redundant when you consider how insidiously crucified MSers will be when next week's budget is announced. Hardly seems celebratory. More shameful if anything.
Hmm, sorry anonymous 1.30pm but I don't understand the correlation. Why is this progress redundant because of the budget? It may well be bad for people with MS, along with a lot of people with other illness and/or facing poverty. Most likely it will be but right now that is speculation and doesn't help anyone. The Conservatives certainly show an absence of empathy and anyone with a illness will be feeling nervous but I fail to understand how this negates moving forward on research for MS. I'd rather see the positive than the negative and will deal with the budget outcome when it happens.
The question that needs to be answered is why no treatments come out of this London based MS research. We have world class researchers in London (Imperial, UCL, Queen Mary's), but the research and trials, to date, have not delivered a single treatment. I know you will point to MS Smart trial, but even if results are positive, we are likely to end up in a Simvastin trial. Until MSers actually benefit from all this work, the work remains just academic.
Tysabri came from the Miller lab but as there are no pharma in London. One of beta interferon inventors ended up in london.
Yep, don't confuse activity with accomplishment. Churning out EAE papers are nice for the CV but where are the breakthroughs?
remember on two ms drugs had their origin in ms. the others have their origi. in immumologh not neuroscience
Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.